Skip to main content

FDA recall, , Moderate risk

Cardinal Health Monoject Tuberculin Syringes

The outer packaging and blister pack label the product as a 1mL Luer Lock Tuberculin Syringe, but the syringes inside are U-100 Insulin syringes.

What happened

Cardinal Health 200, LLC of Waukegan, Illinois, began a recall on February 27, 2026, of Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock. The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe, but the syringes contained within the packages are U-100 Insulin syringes. The recall involves 198,900 units and was added to the FDA's Enforcement Report on April 2, 2026, with distribution nationwide in the US and in Canada.

The syringes were distributed worldwide, including the US nationwide and Canada.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI and lot code are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777

    UDI-DI
    • 10884521013414
    • 20884521013411
    • 30884521013418
    Lot code
    • 531164X
    • 531162X

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the country of Canada.

Company
Cardinal Health 200, LLCWaukegan, Illinois
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98534
Recall number
Z-1768-2026
Quantity recalled
198,900 units

All recalls from Cardinal Health 200, LLC

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)